NCT03073525 2023-04-05A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological CancersGradalis, Inc.Phase 2 Completed25 enrolled 15 charts
NCT02725489 2021-01-27Pilot Study of Durvalumab and Vigil in Advanced Women's CancersMary Crowley Medical Research CenterPhase 2 Completed13 enrolled